FOCAL POINTS (Courageous Discourse™)

FOCAL POINTS (Courageous Discourse™)

Antiviral Therapy for Monkeypox

Contemporary Review Highlights Advances in Treatment

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Sep 02, 2024
∙ Paid
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

With the current Monkeypox Public Health Emergency of International Concern declared by the WHO, a lead organization in the Bio-Pharmaceutical Complex, questions are coming in on how to treat a case of Monkeypox if it was recognized in a gay or bisexual man with the characteristic pox lesions around the anus or buttocks or mouth.

Pourkarim and Entezari-Maleki reviewed three antivirals that have had clinical use in the syndrome. The best-known is FDA approved tecovirimat which is available orally and intravenously.

User's avatar

Continue reading this post for free, courtesy of Peter A. McCullough, MD, MPH.

Or purchase a paid subscription.
© 2026 Peter McCullough MD MPH · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture